Policy Briefings

Section 232 Pharma Tariffs Expand Today: What Manufacturers Need to Know

MFN Deal Includes Revenue-Sharing With HHS on Overseas Sales

China Aims for 25% of Global First-in-Class Drugs by 2030

AstraZeneca Signs Trump’s Second MFN Drug Pricing Deal

Trump Exempts Generic Drugs from Pharmaceutical Tariffs, Boosting Indian Pharma Stocks

UK Considers Raising NHS Drug Prices to Avoid US Tariffs

Trump Delays 100% Pharma Tariffs to Negotiate Pricing Deals

TrumpRx: Pfizer Signs First Deal for US Drug Platform

Trump’s 100% Pharma Tariffs to United States from October 1: How the industry is responding

Trump Administration Draws Autism-Acetaminophen Link Despite Scientific Skepticism

RFK Jr’s Vaccine Panel Expected to Delay Newborn Hepatitis B Shots Until Age 4

US-EU Trade Deal Caps Pharmaceutical Tariffs at 15%, Averting Higher Levies

Gaelic Laboratories Launches Dual-Source Beta-Lactam Strategy With Athlone

Andelyn Biosciences Begins Commercial Manufacturing of FDA-Approved Fayuvi

mAbxience to Develop and Manufacture Emicizumab Biosimilar for Sandoz

GBI Biomanufacturing Launches SmartScale GMP Platform for Early-Stage Biologics

Cellares Partners With GenomeFrontier to Evaluate Automated Virus-Free CAR-T Manufacturing

WuXi XDC Licenses WuXiTecan-2 ADC Technology to Ona Therapeutics

Quotient Sciences Reports Interim Results From AI-Guided Formulation Study

Kincellis Advanced Therapies Formed Through Kincell and Cellipont Merger

Charles River Laboratories Launches Rapid Cell Banking Programs to Cut Release Timelines

Upperton Gains MHRA Approval for 7,000-Sq.-Ft. Sterile Manufacturing Facility

Piramal Pharma Solutions Adds 4.3 MWp Solar Plant at UK Facility

ProBio and Kun Tuo Partner on Integrated CDMO-CRO Solutions in China

Hovione Opens 31,000-Square-Foot Facility to Double U.S. Spray Drying Capacity

Shilpa Biologicals to Develop and Manufacture PD-1 Biosimilars for MENA

Neuland Expands Peptide Manufacturing Capacity to 7,000 L

EirGenix Opens Taiwan Microbial Facility

Axiom Biosciences Partners With GeneFab on Cell and Gene Therapy Manufacturing

FAREVA Acquires Türkiye Site With Capacity of 445 Million Packs Annually

European CDMO Landscape 2025: Download the latest edition